Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang(Harvard University), Francisco Adrián(Genomics Institute of the Novartis Research Foundation), Wolfgang Jahnke(Novartis Institutes for BioMedical Research), Sandra W. Cowan‐Jacob(Novartis (Switzerland)), Allen G. Li(Genomics Institute of the Novartis Research Foundation), Roxana E. Iacob(Northeastern University), Taebo Sim(Dana-Farber Cancer Institute), John T. Powers(Harvard University), Christine Dierks(Genomics Institute of the Novartis Research Foundation), Fangxian Sun(Genomics Institute of the Novartis Research Foundation), Gui-Rong Guo(Genomics Institute of the Novartis Research Foundation), Qiang Ding(Genomics Institute of the Novartis Research Foundation), Okram Barun(Scripps Research Institute), Yongmun Choi(Dana-Farber Cancer Institute), Amy Wojciechowski(Dana-Farber Cancer Institute), Xianming Deng(Harvard University), Guoxun Liu(Genomics Institute of the Novartis Research Foundation), Gabriele Fendrich(Novartis (Switzerland)), André Strauss(Novartis Institutes for BioMedical Research), Navratna Vajpai(University of Basel), Stephan Grzesiek(University of Basel), Tove Tuntland(Genomics Institute of the Novartis Research Foundation), Yi Liu(Genomics Institute of the Novartis Research Foundation), Badry Bursulaya(Genomics Institute of the Novartis Research Foundation), Mohammad Azam(University of Massachusetts Boston), Paul W. Manley(Novartis Institutes for BioMedical Research), John R. Engen(Northeastern University), George Q. Daley(Dana-Farber Cancer Institute), Markus Warmuth, Nathanael S. Gray(Harvard University)
Cited by 599
Abstract
Related Papers
No related papers found
Powered by citation graph analysis